- Home
- CAAS vs IVA Comparison
CAAS vs IVA Comparison
Compare CAAS & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAAS
- IVA
- Stock Information
- Founded
- CAAS N/A
- IVA 2011
- Country
- CAAS China
- IVA France
- Employees
- CAAS N/A
- IVA N/A
- Industry
- CAAS Auto Parts:O.E.M.
- IVA Biotechnology: Pharmaceutical Preparations
- Sector
- CAAS Consumer Discretionary
- IVA Health Care
- Exchange
- CAAS Nasdaq
- IVA Nasdaq
- Market Cap
- CAAS 137.0M
- IVA 162.8M
- IPO Year
- CAAS N/A
- IVA 2020
- Fundamental
- Price
- CAAS $4.17
- IVA $2.94
- Analyst Decision
- CAAS
- IVA Strong Buy
- Analyst Count
- CAAS 0
- IVA 4
- Target Price
- CAAS N/A
- IVA $13.25
- AVG Volume (30 Days)
- CAAS 59.0K
- IVA 7.6K
- Earning Date
- CAAS 03-28-2025
- IVA 03-26-2025
- Dividend Yield
- CAAS N/A
- IVA N/A
- EPS Growth
- CAAS N/A
- IVA N/A
- EPS
- CAAS 0.99
- IVA N/A
- Revenue
- CAAS $650,935,000.00
- IVA $15,243,814.00
- Revenue This Year
- CAAS $4.97
- IVA $18.05
- Revenue Next Year
- CAAS N/A
- IVA $46.74
- P/E Ratio
- CAAS $4.46
- IVA N/A
- Revenue Growth
- CAAS 12.94
- IVA N/A
- 52 Week Low
- CAAS $3.34
- IVA $1.53
- 52 Week High
- CAAS $5.37
- IVA $3.98
- Technical
- Relative Strength Index (RSI)
- CAAS 41.76
- IVA 52.48
- Support Level
- CAAS $4.17
- IVA $2.88
- Resistance Level
- CAAS $5.37
- IVA $3.10
- Average True Range (ATR)
- CAAS 0.27
- IVA 0.18
- MACD
- CAAS -0.03
- IVA -0.02
- Stochastic Oscillator
- CAAS 5.44
- IVA 54.55
About CAAS China Automotive Systems Inc.
China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, more than 310 models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.